Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Abcg2 expressing VESC in adult heart

ABSTRACT: Abcg2 expressing vascular endothelial stem cells (AbcVESC) in adult murine heart promote vessel regeneration after cardiac infarction injury. Here we compared H3.3 K4Me3, K27Me3 modifications between AbcVESC and mature EC

ORGANISM(S): Mus musculus

PROVIDER: GSE225987 | GEO | 2023/05/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Next-generation sequencing analysis of Abcg2-expressing vascular endothelial stem cells and mature endothelial cells

Project description:We have identified that ATP binding Cassette Subfamily G Member 2 (Abcg2) lables vascular endothelial stem cells (VESC) that can for endothelial cell (EC) colonies in vitro and functional vessels in vivo. Here we compared the transcriptome between Abcg2-expressing VESC and Abcg2- mature EC from multiple murine tissues.

2018-12-18 | GSE123999 | GEO

Abcg2 expressing VESC in adult heart

Project description:Abcg2 expressing VESC in adult heart

| PRJNA938150 | ENA

Hyperbaric Oxygen Promotes Both the Proliferation and Chemosensitization of Glioblastoma Cells by Inhibiting HIF1α/HIF2α-ABCG2

Project description:Hyperbaric oxygen enhances glioma chemosensitivity, but the mechanism remains unclear. Hypoxia is common in gliomas, and as the main effector molecules of hypoxia, HIF1α and HIF2α promote the malignant progression by inhibiting cell apoptosis and maintaining stemness. ABCG2 is a marker protein of tumor stem cells and drug efflux transporter protein. This study aims to reveal the detailed mechanism of hyperbaric oxygen promote both proliferation and chemosensitization. Under hyperbaric oxygen and hypoxic conditions, we investigated the differences in cell cycle, proliferation, apoptosis, LDH release, and the expression of proteins and mRNA. We also conducted studies on transcriptional regulation and performed in vivo experiments. It revealed that under hypoxic conditions, HIF1α, HIF2α, and ABCG2 are highly expressed, and both HIF1α and HIF2α promote ABCG2 expression. After hyperbaric oxygen treatment, the expression of HIF1α, HIF2α, and ABCG2 decreased, both cell proliferation and chemosensitivity increased. After knocking out HIF1α and HIF2α, cell proliferation and chemosensitivity increased, but the expression of stem cell marker proteins decreased. ChIP‒qPCR revealed that HIF1α and HIF2α target the ABCG2 promoter. Gain- and loss-of-function experiments suggested that ABCG2 can promote the expression of stem cell marker proteins, inhibit cell apoptosis, and promote tumor progression. This study confirmed that hyperbaric oxygen can inhibit ABCG2 expression through HIF1α and HIF2α, thereby promoting the proliferation and chemosensitization of gliomas.

2025-04-30 | GSE295278 | GEO

RNA-sequencing of Panc-1 cells with ABCG2 over-expression

Project description:The goal of this study was to determine whether the selected sgRNAs increases expression of ABCG2 and whether there are other significant off-target effects

2020-06-01 | GSE131596 | GEO

the expression of ABCG2 in colorectal carcinoma

Project description:Interventions: Case series:Nil Primary outcome(s): ABCG2 Study Design: Single arm

| 2689472 | ecrin-mdr-crc

Next-generation sequencing analysis of Abcg2-expressing vascular endothelial stem cells and mature endothelial cells

Project description:Next-generation sequencing analysis of Abcg2-expressing vascular endothelial stem cells and mature endothelial cells

| PRJNA510477 | ENA

Posttranslational modification of ABCG2-Q141K

Project description:The analysis of posttranslational modification of Q141K of ABCG2 protein

2022-12-19 | PXD030512 | JPOST Repository

OCT4 has an atheroprotective role in endothelial cells by preventing metabolic and phenotypic dysfunction

Project description:Until recently, the pluripotency factor OCT4 was believed to be dispensable in adult somatic cells. However, our recent studies provided clear evidence that OCT4 has a critical atheroprotective role in smooth muscle cells (SMC). Here, we demonstrate that OCT4 controls endothelial cell (EC) phenotypic modulation in atherosclerosis. We establish a new atheroprotective function for OCT4, in that EC-specific Oct4 knockout resulted in increased lipid and LGALS3+ cell accumulation, and altered plaque characteristics consistent with decreased plaque stability. A combination of single-cell RNA sequencing and EC-lineage-tracing studies revealed increased EC activation, endothelial-to-mesenchymal transitions, plaque neovascularization, and mitochondrial dysfunction in the absence of OCT4. We show that ATP transporter, ABCG2, is a direct target of OCT4 in EC, and establish for the first time that the OCT4/ABCG2 axis maintains EC metabolic homeostasis by regulating intracellular heme accumulation and related reactive oxygen species production, which, in turn, contributes to atherogenesis. These results provide the first direct evidence that OCT4 has a protective metabolic function in EC, and identifies vascular OCT4 and its signaling axis as a potential target for novel therapeutics.

2022-04-02 | GSE162119 | GEO

RNA-sequencing of Panc-1 cells with ABCG2 over-expression

Project description:RNA-sequencing of Panc-1 cells with ABCG2 over-expression

| PRJNA544110 | ENA

ABCG2 is an itaconate exporter that limits TFEB-mediated lysosomal biogenesis to impair antibacterial innate immunity

Project description:Itaconate is a metabolite that synthesized from cis-aconitate in mitochondria and transported into cytosol to exert multiple regulatory effects in macrophages. However, the mechanism by which itaconate exits from the cytosol of activated macrophages remains unknown. Using a genetic screen, we reveal that cytosolic itaconate is exported by ABCG2, an ATP-binding cassette (ABC) transporter, in an ATPase-dependent manner in human and mouse macrophages.

2024-05-01 | GSE225712 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data